Diagnostic Accuracy of Prostate Specific Membrane Antigen 18F-DCFPyL PET/CT in Prostate Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT With 18F-DCFPyL in Prostate Cancer Patients (OSPREY)
J Urol 2021 Jul 01;206(1)52-61, KJ Pienta, MA Gorin, SP Rowe, PR Carroll, F Pouliot, S Probst, L Saperstein, MA Preston, AS Alva, A Patnaik, JC Durack, N Stambler, T Lin, J Jensen, V Wong, BA Siegel, MJ MorrisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.